Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Neoplasms of the CNS

Free Subscription 16.02.2026 1 Acta Neuropathol 2 AJNR Am J Neuroradiol 3 BMC Cancer 4 Childs Nerv Syst 2 Int J Radiat Oncol Biol Phys 14 J Neurooncol 1 J Neuropathol Exp Neurol 1 J Neurosurg 2 Neuro Oncol 2 Neuroradiology 5 Neurosurgery 1 Oncogene 2 PLoS One 2 Radiologia (Engl Ed)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. FUJIMOTO K, Honda-Kitahara M, Hattori N, Matsushita Y, et al
   Long-term administration of the mutant IDH inhibitor DS-1001b suppresses the growth of IDH1-mutant glioma in vitro and in mouse xenograft models and alters epigenetic profiles.
   Acta Neuropathol. 2026;151:15.
   PubMed         Abstract available
   
   

   
   AJNR Am J Neuroradiol

2. NADEEM M, Shaheen A, Chaudhary MFA, Mohy-Ud-Din H, et al
   Towards robust and generalizable radio(gen)omics predictive models for brain tumor characterization.
   AJNR Am J Neuroradiol. 2026 Feb 12:ajnr.A9229. doi: 10.3174/ajnr.A9229.
   PubMed         Abstract available
   
   
3. LEE RS, LaBella D, Zhang J, Magudia K, et al
   Evaluating Sociodemographic Biases in Artificial Intelligence-Based Glioblastoma Response Assessment Algorithms.
   AJNR Am J Neuroradiol. 2026 Feb 9:ajnr.A9217. doi: 10.3174/ajnr.A9217.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. ZHONG W, Wu S, Zhu R, Shi H, et al
   Optimal sequencing of brain radiotherapy and immunotherapy for patients with non-small cell lung cancer and driver gene-negative, asymptomatic brain metastases.
   BMC Cancer. 2026 Feb 15. doi: 10.1186/s12885-026-15706.
   PubMed        
   
   
5. SUCUOGLU ISLEYEN Z, Secmeler S, Sakin A, Cihan S, et al
   Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study.
   BMC Cancer. 2026 Feb 14. doi: 10.1186/s12885-026-15725.
   PubMed         Abstract available
   
   
6. LI X, Li Z, Duan X, Liang Q, et al
   Machine learning-based radiopathomics ensemble model for predicting multiple molecular subtypes of adult diffuse glioma: a multicenter retrospective study.
   BMC Cancer. 2026 Feb 10. doi: 10.1186/s12885-026-15645.
   PubMed        
   
   

   
   Childs Nerv Syst

7. HAYASHI Y, Takata S, Kimura R, Ogiwara T, et al
   Asymptomatic arachnoid cysts turning symptomatic after sports-related concussion injury: a report of two cases.
   Childs Nerv Syst. 2026;42:72.
   PubMed         Abstract available
   
   
8. KARAASLAN MM, Aydin MH, Kuzucu P, Borcek AO, et al
   Spontaneous rupture of an arachnoid cyst with subdural hygroma formation: a rare case report and literature review.
   Childs Nerv Syst. 2026;42:69.
   PubMed         Abstract available
   
   
9. POWER EA, Pumford AD, Futso-Kamga L, Silvera VM, et al
   Influence of subgroup, location, and tumor volume in medulloblastoma surgery and consideration for second look surgery: a single institution experience.
   Childs Nerv Syst. 2026;42:67.
   PubMed         Abstract available
   
   
10. SINGH A, Patel S, Gould J, Yaffe N, et al
    Clinical predictors of overall survival in pediatric patients with intramedullary spinal tumors: an analysis of the SEER database.
    Childs Nerv Syst. 2026;42:63.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

11. SCHMITT LG, Dohopolski M, de Vis J, Mostardeiro TR, et al
    Adaptive MRI-Guided Reirradiation for High-Risk Recurrent Grade 4 Gliomas: Early Clinical Outcomes and Volumetric Response.
    Int J Radiat Oncol Biol Phys. 2026 Feb 7:S0360-3016(26)00329.
    PubMed         Abstract available
    
    
12. LIU Z, Zhao S, Mitchell TJ, Luo C, et al
    The dose-dependent relationship of medial temporal network, parietal memory network, and visual network on episodic memory decline following chemoradiotherapy in patients with diffuse gliomas.
    Int J Radiat Oncol Biol Phys. 2026 Feb 11:S0360-3016(26)00385.
    PubMed         Abstract available
    
    

    
    J Neurooncol

13. MEL'NIKOV MY, Shakhzadayev R, Baiturlin Z, Batyrkhanov D, et al
    Frequency-specific resting state fMRI features in gliomas.
    J Neurooncol. 2026;176:198.
    PubMed        
    
    
14. KITE T, Hanft S, Zeller S, Lee S, et al
    Local control and leptomeningeal disease after resection and GammaTile brachytherapy for newly diagnosed brain metastases: results from a prospective registry.
    J Neurooncol. 2026;176:199.
    PubMed         Abstract available
    
    
15. JANKOVIC D, Thavarajasingam SG, Scurtu D, Baby MV, et al
    Maximal resection improves survival in MGMT methylated very elderly glioblastoma patients.
    J Neurooncol. 2026;176:202.
    PubMed         Abstract available
    
    
16. MIRIAN C, Jensen LR, Hoffmann AG, Juratli TA, et al
    Fractionated radiotherapy adjuvant to surgery of WHO-2 meningioma with and without gross total resection: a multicenter, retrospective cohort study of 1,452 patients.
    J Neurooncol. 2026;176:201.
    PubMed         Abstract available
    
    
17. MORAES FY, Isen J, Perry J, Laperriere N, et al
    Correction to: Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.
    J Neurooncol. 2026;176:200.
    PubMed        
    
    
18. STEELE EM, Hall JT, Lui K, Darawsheh R, et al
    Symptomatic radiation necrosis after concurrent targeted therapy and stereotactic radiosurgery for brain metastases: a bicentric retrospective analysis.
    J Neurooncol. 2026;176:203.
    PubMed        
    
    
19. PURI S, Sloan L, Doucet M, Katulis L, et al
    Radiation immunodynamics: association of baseline and longitudinal cytokine levels during radiotherapy in glioblastoma with survival.
    J Neurooncol. 2026;176:204.
    PubMed        
    
    
20. RAMSEY KA, Byrne L, Taylor OB, Soliman A, et al
    High frequency and unique subtypes of meningioma in patients with BAP1 tumor predisposition syndrome.
    J Neurooncol. 2026;176:207.
    PubMed         Abstract available
    
    
21. BIYIKLI E, Aybal T, Aslan B, Gul D, et al
    Prognostic role of delta radiomics in pediatric pontine diffuse midline gliomas.
    J Neurooncol. 2026;176:206.
    PubMed         Abstract available
    
    
22. LOUGHAN AR, Braun SE, Lanoye A, Willis K, et al
    Post-traumatic growth in patients and caregivers after a primary brain tumor diagnosis.
    J Neurooncol. 2026;176:208.
    PubMed         Abstract available
    
    
23. TOLL SA, Rechberger JS, Chow WD, Biswas S, et al
    Update of NK cell therapy in pediatric brain tumors.
    J Neurooncol. 2026;176:209.
    PubMed        
    
    
24. DENIZ B, Arpaci MF, Pekmez H, Uzun GB, et al
    Investigation of the effects of radiotherapy and chemotherapy on brain volume in cancer patients: brain tumor study.
    J Neurooncol. 2026;176:210.
    PubMed         Abstract available
    
    
25. YAMASHITA S, Kanamori M, Kubozono M, Shimoda Y, et al
    Consolidation reduced-dose whole-brain radiation therapy with response-adapted boost in older patients with newly diagnosed primary central nervous system lymphoma.
    J Neurooncol. 2026;176:211.
    PubMed         Abstract available
    
    
26. MC CARTHY L, Andersen BM, Wen PY, Reardon DA, et al
    Meta-analysis of treatment-emergent seizures in glioma vaccine trials.
    J Neurooncol. 2026;176:212.
    PubMed        
    
    

    
    J Neuropathol Exp Neurol

27. NISHIDA N, Hata Y
    Sudden unexpected death associated with previously undiagnosed gliomas: A mechanism-based interpretation of three autopsy cases.
    J Neuropathol Exp Neurol. 2026 Feb 14:nlag006. doi: 10.1093.
    PubMed        
    
    

    
    J Neurosurg

28. ABI FARAJ C, McCutcheon IE, Strickland BA, Debnam JM, et al
    Ventricular entry and postoperative leptomeningeal metastasis after resection of supratentorial high-grade glioma.
    J Neurosurg. 2026 Feb 13:1-15. doi: 10.3171/2025.9.JNS25526.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

29. IPPEN FM, Hielscher T, Patel A, Friedel D, et al
    The prognostic impact of CDKN2A/B hemizygous deletions in meningioma.
    Neuro Oncol. 2026 Feb 11:noag024. doi: 10.1093.
    PubMed         Abstract available
    
    
30. DRAPER B, You Z, Thompson D, Guo X, et al
    MIF-CD74 signaling drives immune modulation in medulloblastoma.
    Neuro Oncol. 2026 Feb 6:noag020. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neuroradiology

31. YASAKA K, Katayama A, Sakamoto N, Sato Y, et al
    Pituitary neuroendocrine tumor: evaluation with super resolution deep learning reconstruction : Research.
    Neuroradiology. 2026;68:105-113.
    PubMed         Abstract available
    
    
32. ZHU R, Li Z, Hou Z, Koh TS, et al
    The diagnostic and prognosis value of dynamic contrast-enhanced MRI distributed parameter model and (18)F- fluoroethyltyrosine PET on differentiating recurrent glioma from treatment-induced change.
    Neuroradiology. 2026 Feb 10. doi: 10.1007/s00234-026-03926.
    PubMed        
    
    

    
    Neurosurgery

33. CHUNG JH, Tos SM, Mantziaris G, Shinya Y, et al
    Stereotactic Radiosurgery Dose Reduction for Patients With Brain Metastases From Non-Small Cell Lung Primary on Immunotherapy or Targeted Therapy.
    Neurosurgery. 2026 Feb 12. doi: 10.1227/neu.0000000000003961.
    PubMed         Abstract available
    
    
34. ODLAND IC, Huo L, Feng R, Tabani H, et al
    Standalone Meningioma Embolization: A Systematic Review.
    Neurosurgery. 2026 Feb 9. doi: 10.1227/neu.0000000000003933.
    PubMed         Abstract available
    
    
35. SPOLAORE A, Wang S, Gorbachuk M, Machetanz K, et al
    Voxel-Based Mapping of Seizure Risk in Meningioma Identifies the Frontoparietal Interface and Tumor Microenvironment as Key Predictors.
    Neurosurgery. 2026 Feb 9. doi: 10.1227/neu.0000000000003943.
    PubMed         Abstract available
    
    
36. KHAN AB, McDonald MF, English C, Nouri SH, et al
    Integrated Clinical Genetic Analysis Reveals Transcriptional Neurotransmitter Receptor Dysregulation in Meningiomas Causing Seizure.
    Neurosurgery. 2026 Feb 12. doi: 10.1227/neu.0000000000003931.
    PubMed         Abstract available
    
    
37. SHAH I, Gomez D, Liu KG, Cote DJ, et al
    T2-Weighted MRI Signal Intensity Ratio Predicts Intraoperative Intracranial Meningioma Consistency: A Retrospective Cohort Study.
    Neurosurgery. 2026 Feb 12. doi: 10.1227/neu.0000000000003956.
    PubMed         Abstract available
    
    

    
    Oncogene

38. LI W, Huo R, Liu S, He K, et al
    Brain-cancer interactions outside the CNS.
    Oncogene. 2026;45:715-727.
    PubMed         Abstract available
    
    

    
    PLoS One

39. MOAZEN SAFAEI Y, Mahdavian R, Soleymani H, Rahimpour N, et al
    A comparative investigation of catecholamines and glucocorticoids impact on glioblastoma invasive behavior via 2D and 3D cell culture.
    PLoS One. 2026;21:e0339764.
    PubMed         Abstract available
    
    
40. DE JONG AM, van der Boog ATJ, Post CCB, Cialdella F, et al
    Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG).
    PLoS One. 2026;21:e0342337.
    PubMed         Abstract available
    
    

    
    Radiologia (Engl Ed)

41. ONG SRK, Rohringer TJ, Gao AF, Para AE, et al
    Spontaneous contrast enhancement fluctuation in adult pilocytic astrocytoma.
    Radiologia (Engl Ed). 2026;68:101658.
    PubMed         Abstract available
    
    
42. MALDONADO F, Guarnizo A, Geraldo AF, Baroni L, et al
    Update to non-medulloblastoma embryonal tumours: What neuroradiologists should know.
    Radiologia (Engl Ed). 2026;68:101629.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum